PMA device
Vercise Deep Brain Stimulation (Dbs) System
Boston Scientific Corp · Stimulator, Electrical, Implanted, For Parkinsonian Symptoms (NHL, Class III) · First FDA decision Dec 8, 2017, newest Sep 13, 2026DystoniaEssential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
24
Naming "Vercise Deep Brain"
MAUDE reports
0
Brand "Vercise Deep Brain", since 2015
PubMed studies
0
Mentioning "Vercise Deep Brain"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vercise Deep Brain Stimulation (Dbs) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 3 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Vercise Deep Brain", any status and sponsor, newest update first.
- Vercise™ DBS Dystonia Prospective StudyRecruiting
Boston Scientific CorporationPublic (BSX)
NCT02686125 · 300 participants (planned) · Start Mar 7, 2016 · Primary completion Dec 2030
Device: Deep Brain Stimulation (DBS) · For: Dystonia
Sites: Ghent, Belgium; Leuven, Belgium; Halifax, Canada · 36 sites in all
Boston Scientific CorporationPublic (BSX)
NCT02071134 · 1,500 participants (planned) · Start Mar 4, 2014 · Primary completion Dec 2038
Device: Deep Brain Stimulation (DBS) · For: Parkinson's Disease
Sites: Aliso Viejo, California; Los Angeles, California; Aurora, Colorado · 87 sites in all
- Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective ProcessingEnrolling by invitation
Baylor College of MedicineAcademic, hospital or other
NCT05418894 · 84 participants (planned) · Start Apr 1, 2022 · Primary completion Mar 31, 2031
Device: Device: Directional Deep Brain Stimulation · For: Treatment Resistant Depression; Epilepsy
Sites: Houston, Texas
21 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vercise Deep Brain", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NHL
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vercise Deep Brain"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NHL.
- Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS SystemBoston Scientific Corp · PMA 2024
- Vercise PC DBS System, Vercise Gervia DBS System, Vercise Genus DBS SystemBoston Scientific Corp · PMA 2024
- Vercise DBS System / Vercise PC DBS SystemBoston Scientific Corp · PMA 2018
- Activa®, Percept and SenSight Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2025
- Vercise DBS ControllerBoston Scientific Corp · PMA 2025
- Vercise S8 AdapterBoston Scientific Corp · PMA 2023
- Vercise Genus Deep Brain Stimulation (DBS) SystemBoston Scientific Corp · PMA 2021
- Vercise Gevia DBS System and Directional Lead-only SystemBoston Scientific Corp · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.